Global Medical REIT (GMRE) Given Coverage Optimism Score of 0.03

Media coverage about Global Medical REIT (NYSE:GMRE) has been trending somewhat positive on Friday, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Global Medical REIT earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave news articles about the company an impact score of 46.2576048631554 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Global Medical REIT (GMRE) traded up $0.07 during midday trading on Friday, reaching $8.38. The company had a trading volume of 102,500 shares, compared to its average volume of 131,575. The company has a quick ratio of 0.22, a current ratio of 0.22 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $181.27, a P/E ratio of -41.90, a PEG ratio of 1.38 and a beta of -48.24. Global Medical REIT has a 12 month low of $7.85 and a 12 month high of $10.25.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 10th. Shareholders of record on Tuesday, December 26th were issued a dividend of $0.20 per share. The ex-dividend date was Friday, December 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 9.55%. Global Medical REIT’s dividend payout ratio is presently -400.00%.

Several research firms recently weighed in on GMRE. Zacks Investment Research upgraded Global Medical REIT from a “hold” rating to a “buy” rating and set a $9.50 target price on the stock in a research report on Tuesday. B. Riley reiterated a “buy” rating and set a $10.50 target price on shares of Global Medical REIT in a research report on Friday, November 10th. Finally, FBR & Co reiterated a “buy” rating and set a $10.50 target price (up from $10.00) on shares of Global Medical REIT in a research report on Monday, September 18th. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Global Medical REIT currently has an average rating of “Buy” and an average target price of $10.50.

TRADEMARK VIOLATION WARNING: “Global Medical REIT (GMRE) Given Coverage Optimism Score of 0.03” was reported by Stock Observer and is owned by of Stock Observer. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.thestockobserver.com/2018/01/12/global-medical-reit-gmre-given-coverage-optimism-score-of-0-03.html.

About Global Medical REIT

Insider Buying and Selling by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply